Phase 1 Liver Cancer Trial, Recruiting (NCT06545630)

Phase 1 Liver Cancer Trial, Recruiting NCT06545630 Sponsor: West China Hospital Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06545630 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with colorectal cancer confirmed by a laboratory test (biopsy or tissue sample)
You are generally able to carry out normal daily activities with little or no restriction (confirm with trial site)
Your tumor has been tested and shown to have a specific molecular profile called "pMMR" or "MSS/MSI-L" (confirm with trial site)
Scans show your cancer has spread to other parts of the body (stage IV), but both the original tumor and the spread (metastatic) tumors have been surgically removed, leaving no visible cancer remaining
You are considered at high risk of the cancer coming back — for example, your liver metastasis scored above 3 on a specific risk scale, or you previously needed treatment to shrink the tumor before surgery was possible (confirm with trial site)
You have had surgery to remove multiple areas of cancer spread within the abdomen, with complete removal achieved (confirm with trial site)
Your major organs (such as heart, liver, and kidneys) are working normally
You are willing and able to give written consent to take part in the trial

Who may not be able to join:

You are experiencing a cancer-related emergency
Your blood does not clot properly
You have an infectious disease such as HIV, hepatitis B (HBV), or hepatitis C (HCV)
You have a mental health disorder
You have another type of cancer at the same time
You have a condition affecting your immune system (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 14 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06545630

Sponsor: West China Hospital

Phase: Phase 1

Status: Recruiting

Condition: Liver Cancer

More information: https://clinicaltrials.gov/study/NCT06545630

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with colorectal cancer confirmed by a laboratory test (biopsy or tissue sample)
You are generally able to carry out normal daily activities with little or no restriction (confirm with trial site)
Your tumor has been tested and shown to have a specific molecular profile called "pMMR" or "MSS/MSI-L" (confirm with trial site)
Scans show your cancer has spread to other parts of the body (stage IV), but both the original tumor and the spread (metastatic) tumors have been surgically removed, leaving no visible cancer remaining
You are considered at high risk of the cancer coming back — for example, your liver metastasis scored above 3 on a specific risk scale, or you previously needed treatment to shrink the tumor before surgery was possible (confirm with trial site)
You have had surgery to remove multiple areas of cancer spread within the abdomen, with complete removal achieved (confirm with trial site)
Your major organs (such as heart, liver, and kidneys) are working normally
You are willing and able to give written consent to take part in the trial

Who may not be able to join:

You are experiencing a cancer-related emergency
Your blood does not clot properly
You have an infectious disease such as HIV, hepatitis B (HBV), or hepatitis C (HCV)
You have a mental health disorder
You have another type of cancer at the same time
You have a condition affecting your immune system (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 14 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

West China Hospital

Registry

ClinicalTrials.gov

Start date

1 November 2023

Est. completion

1 November 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov